HK Stock Market Move | LEADS BIOLABS-B(09887) rose by over 11% again, with the stock price increasing by over 30% in the past three days. Multiple research achievements have been selected for the 2026 ESMO.

LEADS BIOLABS-B(09887) surged by more than 11%, with the stock price rising by over 30% in the past three trading days. As of the time of writing, it had risen by 11.45% to reach 67.15 Hong Kong dollars, with a trading volume of 166 million Hong Kong dollars. On the news front, recently Verdiso Biotech announced the selection results of the 2026 ESMO, confirming the inclusion of six latest research outcomes, including two oral presentations of the highest specifications, with an LBA expected to be included in September. Previously, the company also announced that LBL-024 was selected for oral presentation at the World Lung Cancer Conference (WCLC) to be held in September this year. It is worth mentioning that Verdiso Biotech recently disclosed that its core pipeline LBL-024 has qualified for priority review of its market application. The company stated that this milestone marks the official locking of the commercialization timeline for Verlisin and the approval for market listing can be expected. At the same time, the company is actively advancing various commercialization preparations before listing.